New Delhi, Feb 13 (IANS) Health-tech unicorn Pristyn Care is facing a series of high-profile exits amid cost-cutting measures, as the company struggles with cash flow issues, mounting expenses and absence of fresh funding to sustain its business model.
The startup, backed by Peak XV Partners (formerly Sequoia Capital India & SEA), has seen multiple senior executives resign in recent months, while several junior and mid-level employees have also been let go as part of cost-cutting measures.
Among the key departures is Prabhat Agarwal, Senior Vice President of Finance, who has stepped down and is currently serving his notice period, according to media reports. However, the company said he is still “on the rolls”.
Additionally, Tarun Bansal, Senior Vice President of Business and Operations, resigned in June 2024, as per his LinkedIn profile.
Other major exits include Srinivas Reddy P, Senior Vice President of Human Resources, and Gagan Arora, Head of Marketing, both of whom left the company last year.
The company has also undertaken a workforce reduction at the junior and mid-management levels in the last two months, citing underperformance as the reason.
However, its financials suggest that the layoffs are likely to be driven by a severe cash crunch.
Pristyn Care’s financials, accessed by IANS, reveal a growing strain on its resources.
The company’s total expenses soared to Rs 1,013 crore in FY24, up from Rs 876 crore in the previous year, while its operating revenue rose to Rs 600 crore in FY24 from Rs 452 crore in FY23, as per its filings.
Despite revenue growth, Pristyn Care’s cash flow remains abstract, with its cash flows from operating, investing, and financing activities classified as abstract in its filings, suggesting liquidity concerns.
In June 2022, Pristyn Care acquired telemedicine platform Lybrate for a reported $20-30 million to expand into primary healthcare.
However, the company no longer sees value in the acquisition and has been phasing out the platform since last year.
Most Lybrate employees have either been reassigned to other verticals or exited the company.
Adding to its troubles, Pristyn Care is entangled in a legal battle with Lybrate co-founders Saurabh Arora and Rahul Narang, as per reports.
The duo has accused Pristyn Care of failing to pay the full acquisition amount and filed arbitration proceedings in a Delaware court in December 2023, seeking $13 million in damages.
Last year, the healthcare company slashed several hundred jobs in aan apparent restructuring exercise, impacting employees across teams.
–IANS
pk/na
Disclaimer
The information contained in this website is for general information purposes only. The information is provided by TodayIndia.news and while we endeavour to keep the information up to date and correct, we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, reliability, suitability or availability with respect to the website or the information, products, services, or related graphics contained on the website for any purpose. Any reliance you place on such information is therefore strictly at your own risk.
In no event will we be liable for any loss or damage including without limitation, indirect or consequential loss or damage, or any loss or damage whatsoever arising from loss of data or profits arising out of, or in connection with, the use of this website.
Through this website you are able to link to other websites which are not under the control of TodayIndia.news We have no control over the nature, content and availability of those sites. The inclusion of any links does not necessarily imply a recommendation or endorse the views expressed within them.
Every effort is made to keep the website up and running smoothly. However, TodayIndia.news takes no responsibility for, and will not be liable for, the website being temporarily unavailable due to technical issues beyond our control.
For any legal details or query please visit original source link given with news or click on Go to Source.
Our translation service aims to offer the most accurate translation possible and we rarely experience any issues with news post. However, as the translation is carried out by third part tool there is a possibility for error to cause the occasional inaccuracy. We therefore require you to accept this disclaimer before confirming any translation news with us.
If you are not willing to accept this disclaimer then we recommend reading news post in its original language.
